Gilead Sciences
• Five diverse research projects spanning COVID-19, HIV, hepatitis C elimination, CAR T cell therapy and fungal infections are the 2021 recipients of the Gilead Fellowship Research Grant.
• Now in its 11th year, the Fellowship has granted more than $2.6 million to research projects throughout Australia which often struggle to secure funding or face high competition.
Melbourne, 29 June 2021 – Gilead Sciences Australia today announced the five recipients of the 2021 Gilead Fellowship Research Grants Program one of which will investigate the medium- and long-term impacts of COVID-19 on patients’ health and wellbeing.
Grant recipient Professor Kumar Visvanathan, Infectious Diseases Physician, Academic Lead of Medicine at the University of Melbourne campus and Co-Director of the Immunology Research Centre at St Vincent’s Hospital, Melbourne will follow almost 100 individuals with confirmed COVID-19 infection over a six month period to look at COVID-19’s imp
Programm Babylotse: Hamburgische Bürgerschaft beschließt Erhöhung der Landesmittel / Mehr Hilfen für Hamburger Familien - Politikexpress
politikexpress.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from politikexpress.de Daily Mail and Mail on Sunday newspapers.
New Cal/OSHA COVID-19 Standards Relax Workplace Restrictions | Morrison & Foerster LLP
jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.
CSRWire - Safety Month: Continuing Our Safety Culture Year-Round
csrwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from csrwire.com Daily Mail and Mail on Sunday newspapers.
California adopts new workplace COVID-19 rules - 3 key takeaways | Dentons
jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.